1. Home
  2. Publications
  3. Publications of type "Paper"

Publications of type "Paper"

Enter any text in the title of the paper (e.g. 'Breast'; 'Scotland')
The full UKIACR member associated with this publication

  1. Negative screening colonoscopy after a positive guaiac faecal occult blood test: not a contraindication to continued screening.

    Carrera A, McClements PL, Watling C, Libby G, Weller D, Brewster DH, Carey FA, Fraser CG, Steele RJ
    Colorectal Dis. 2012 Aug; 14(8):943-6. PMID: 21981347

  2. Incidence and survival for hepatic, pancreatic and biliary cancers in England between 1998 and 2007.

    Coupland VH, Kocher HM, Berry DP, Allum W, Linklater KM, Konfortion J, Møller H, Davies EA
    Cancer Epidemiol. 2012 Aug; 36(4):e207-14. PMID: 22534487

  3. Second primary malignancies among women with uterine sarcoma.

    Koivisto-Korander R, Scélo G, Ferro G, Mellemkjaer L, Hemminki K, Weiderpass E, Tamaro S, Pompe-Kirn V, Tracey E, Brewster DH, Kliewer EV, Tonita JM, Kee-Seng C, Jonasson JG, Martos C, Brennan P, Straif K, Pukkala E
    Gynecol Oncol. 2012 Jul; 126(1):30-5. PMID: 22487538

  4. The impact of population-based faecal occult blood test screening on colorectal cancer mortality: a matched cohort study

    Libby G, Brewster DH, McClements PL, Carey FA, Black RJ, Birrell J, Fraser CG, Steele RJ
    Br J Cancer 2012; 107: 255-9 PMID: 22735907

  5. Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence.

    Johnson JA, Carstensen B, Witte D, Bowker SL, Lipscombe L, Renehan AG
    Diabetologia. 2012 Jun; 55(6):1607-18. PMID: 22476947

  6. Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer.

    Renehan AG, Yeh HC, Johnson JA, Wild SH, Gale EA, Møller H
    Diabetologia. 2012 Jun; 55(6):1619-32. PMID: 22476948

  7. Socioeconomic inequalities in incidence of lung and upper aero-digestive tract cancer by age, tumour subtype and sex: A population-based study in Scotland (2000-2007)

    Sharpe KH, McMahon AD, McClements P, Watling C, Brewster DH, Conway DI
    Cancer Epidemiol. 2012 Jun; 36(3):e164-70. Epub 2012 Mar 20 PMID: 22436397

  8. Social differences in lung cancer management and survival in South East England: a cohort study.

    Berglund A, Lambe M, Lüchtenborg M, Linklater K, Peake MD, Holmberg L, Møller H
    BMJ Open. 2012; 2(3) PMID: 22637374

  9. Major ethnic group differences in breast cancer screening uptake in Scotland are not extinguished by adjustment for indices of geographical residence, area deprivation, long-term illness and education.

    Bansal N, Bhopal RS, Steiner MF, Brewster DH
    Br J Cancer. 2012 Apr 10; 106(8):1361-6. PMID: 22415231

  10. The incidence of basal cell carcinoma in the under-30s in the UK

    Skellett AM, Hafiji J, Greenberg DC, Wright KA, Levell NJ
    Clin Exp Dermatol. 2012 Apr; 37(3):227-9. doi: 10.1111/j.1365-2230.2011.04246.x. Epub 2011 Dec 23 PMID: 22211923

  11. Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site

    Steele RJ, McClements P, Watling C, Libby G, Weller D, Brewster DH, Black R, Carey FA, Fraser CG
    Gut. 2012 Apr; 61(4):576-81. Epub 2011 Sep 19 PMID: 21930729

  12. Cardiovascular disease and air pollution in Scotland: no association or insufficient data and study design?

    Willocks LJ, Bhaskar A, Ramsay CN, Lee D, Brewster DH, Fischbacher CM, Chalmers J, Morris G, Scott EM.
    BMC Public Health 2012;12:227 PMID: 22440092

  13. Variation in advanced stage at diagnosis of lung and female breast cancer in an English region 2006-2009.

    Lyratzopoulos G, Abel GA, Barbiere JM, Brown CH, Rous BA, Greenberg DC
    Br J Cancer. 2012 Mar 13; 106(6):1068-75. PMID: 22382691

  14. Trends in incidence of small cell lung cancer and all lung cancer.

    Riaz SP, Lüchtenborg M, Coupland VH, Spicer J, Peake MD, Møller H
    Lung Cancer. 2012 Mar; 75(3):280-4. PMID: 21893364

  15. The association of diagnosis in the private or NHS sector on prostate cancer stage and treatment.

    Barbiere JM, Greenberg DC, Wright KA, Brown CH, Palmer C, Neal DE, Lyratzopoulos G
    J Public Health (Oxf). 2012 Mar; 34(1):108-14. PMID: 21745831

  16. Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort.

    Cuzick J, Berney DM, Fisher G, Mesher D, Møller H, Reid JE, Perry M, Park J, Younus A, Gutin A, Foster CS, Scardino P, Lanchbury JS, Stone S
    Br J Cancer. 2012 Mar 13; 106(6):1095-9. PMID: 22361632

  17. Breast cancer and age in Black and White women in South East England.

    Jack RH, Davies EA, Møller H
    Int J Cancer. 2012 Mar 1; 130(5):1227-9. PMID: 21445965

  18. Population-based estimates of the occurrence of multiple vs first primary basal cell carcinomas in 4 European regions.

    de Vries E, Micallef R, Brewster DH, Gibbs JH, Flohil SC, Saksela O, Sankila R, Forrest AD, Trakatelli M, Coebergh JW, Proby CM
    Arch Dermatol. 2012 Mar; 148(3):347-54. PMID: 22431775

  19. Impact of the UK colorectal cancer screening pilot studies on incidence, stage distribution and mortality trends

    McClements PL, Madurasinghe V, Thomson CS, Fraser CG, Carey FA, Steele RJ, Lawrence G, Brewster DH
    Cancer Epidemiol. 2012; 36(4): e232-42 PMID: 22425027

  20. A comparison of prostate cancer survival in England, Norway and Sweden: a population-based study.

    Holmberg L, Robinson D, Sandin F, Bray F, Linklater KM, Klint A, Lambert PC, Adolfsson J, Hamdy FC, Catto J, Møller H
    Cancer Epidemiol. 2012 Feb; 36(1):e7-12. PMID: 21907655